Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

78 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S. Thorén M, et al. Among authors: saaf m. J Bone Miner Res. 1998 May;13(5):891-9. doi: 10.1359/jbmr.1998.13.5.891. J Bone Miner Res. 1998. PMID: 9610754 Free article.
Risk of hip fracture in Addison's disease: a population-based cohort study.
Björnsdottir S, Sääf M, Bensing S, Kämpe O, Michaëlsson K, Ludvigsson JF. Björnsdottir S, et al. Among authors: saaf m. J Intern Med. 2011 Aug;270(2):187-95. doi: 10.1111/j.1365-2796.2011.02352.x. Epub 2011 Mar 1. J Intern Med. 2011. PMID: 21251095 Free article.
Intravenous zoledronic acid in postmenopausal women with low bone mineral density.
Reid IR, Brown JP, Burckhardt P, Horowitz Z, Richardson P, Trechsel U, Widmer A, Devogelaer JP, Kaufman JM, Jaeger P, Body JJ, Brandi ML, Broell J, Di Micco R, Genazzani AR, Felsenberg D, Happ J, Hooper MJ, Ittner J, Leb G, Mallmin H, Murray T, Ortolani S, Rubinacci A, Saaf M, Samsioe G, Verbruggen L, Meunier PJ. Reid IR, et al. Among authors: saaf m. N Engl J Med. 2002 Feb 28;346(9):653-61. doi: 10.1056/NEJMoa011807. N Engl J Med. 2002. PMID: 11870242 Free article. Clinical Trial.
Stereotactic irradiation for pituitary disease.
Thorén M, Sääf M, Degerblad M, Rähn T, Norén G, Bergstrand CG, Tallstedt L, Backlund EO. Thorén M, et al. Among authors: saaf m. Horm Res. 1988;30(2-3):101-3. doi: 10.1159/000181038. Horm Res. 1988. PMID: 2854818 No abstract available.
Diabetic osteopathy and the IGF system in the Goto-Kakizaki rat.
Ahmad T, Ugarph-Morawski A, Lewitt MS, Li J, Sääf M, Brismar K. Ahmad T, et al. Among authors: saaf m. Growth Horm IGF Res. 2008 Oct;18(5):404-411. doi: 10.1016/j.ghir.2008.02.003. Epub 2008 Apr 1. Growth Horm IGF Res. 2008. PMID: 18381245
Osteoblast dysfunction in male idiopathic osteoporosis.
Pernow Y, Granberg B, Sääf M, Weidenhielm L. Pernow Y, et al. Among authors: saaf m. Calcif Tissue Int. 2006 Feb;78(2):90-7. doi: 10.1007/s00223-005-0158-9. Epub 2006 Feb 6. Calcif Tissue Int. 2006. PMID: 16467976
Skeletal changes in type-2 diabetic Goto-Kakizaki rats.
Ahmad T, Ohlsson C, Sääf M, Ostenson CG, Kreicbergs A. Ahmad T, et al. Among authors: saaf m. J Endocrinol. 2003 Jul;178(1):111-6. doi: 10.1677/joe.0.1780111. J Endocrinol. 2003. PMID: 12844342
Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.
Välimäki MJ, Farrerons-Minguella J, Halse J, Kröger H, Maroni M, Mulder H, Muñoz-Torres M, Sääf M, Snorre Øfjord E. Välimäki MJ, et al. Among authors: saaf m. Clin Ther. 2007 Sep;29(9):1937-49. doi: 10.1016/j.clinthera.2007.09.017. Clin Ther. 2007. PMID: 18035193 Clinical Trial.
One-leg standing time and hip-fracture prediction.
Lundin H, Sääf M, Strender LE, Nyren S, Johansson SE, Salminen H. Lundin H, et al. Among authors: saaf m. Osteoporos Int. 2014 Apr;25(4):1305-11. doi: 10.1007/s00198-013-2593-1. Epub 2014 Feb 22. Osteoporos Int. 2014. PMID: 24562837
Bone histomorphometry in male idiopathic osteoporosis.
Pernow Y, Hauge EM, Linder K, Dahl E, Sääf M. Pernow Y, et al. Among authors: saaf m. Calcif Tissue Int. 2009 Jun;84(6):430-8. doi: 10.1007/s00223-009-9239-5. Epub 2009 Mar 24. Calcif Tissue Int. 2009. PMID: 19308628
Effects of protein-rich nutritional supplementation and bisphosphonates on body composition, handgrip strength and health-related quality of life after hip fracture: a 12-month randomized controlled study.
Flodin L, Cederholm T, Sääf M, Samnegård E, Ekström W, Al-Ani AN, Hedström M. Flodin L, et al. Among authors: saaf m. BMC Geriatr. 2015 Nov 17;15:149. doi: 10.1186/s12877-015-0144-7. BMC Geriatr. 2015. PMID: 26572609 Free PMC article. Clinical Trial.
Calcium and vitamin D for prevention of osteoporotic fractures.
Freyschuss B, Ljunggren O, Saaf M, Mellstrom D, Avenell A. Freyschuss B, et al. Among authors: saaf m. Lancet. 2007 Dec 22;370(9605):2098-9; author reply 2099. doi: 10.1016/S0140-6736(07)61896-0. Lancet. 2007. PMID: 18156022 No abstract available.
[New indicator needed for follow up of osteoporosis patients].
Hermansson J, Blom M, Elinder CG, Ponzer S, Sääf M. Hermansson J, et al. Among authors: saaf m. Lakartidningen. 2016 Feb 15;113:DT3X. Lakartidningen. 2016. PMID: 26881792 Free article. Swedish. No abstract available.
[Endocrine ophthalmopathy and autoimmune thyroid diseases].
Karlsson A, Dahlberg PA, Enoksson P, Boström L, Sääf M, Sjöberg HE, Tallstedt L. Karlsson A, et al. Among authors: saaf m. Lakartidningen. 1985 Jul 10;82(28-29):2504-7. Lakartidningen. 1985. PMID: 4021654 Swedish. No abstract available.
[Endocrine ophthalmopathy and autoimmune thyroid disease].
Karlsson A, Dahlberg PA, Enoksson P, Boström L, Sääf M, Sjöberg HE, Tallstedt L. Karlsson A, et al. Among authors: saaf m. Nord Med. 1985;100(11):298-301. Nord Med. 1985. PMID: 3840885 Swedish. No abstract available.
Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus.
Broesby-Olsen S, Dybedal I, Gülen T, Kristensen TK, Møller MB, Ackermann L, Sääf M, Karlsson MA, Agertoft L, Brixen K, Hermann P, Stylianou E, Mortz CG, Torfing T, Havelund T, Sander B, Bergström A, Bendix M, Garvey LH, Bjerrum OW, Valent P, Bindslev-Jensen C, Nilsson G, Vestergaard H, Hägglund H. Broesby-Olsen S, et al. Among authors: saaf m. Acta Derm Venereol. 2016 Jun 15;96(5):602-12. doi: 10.2340/00015555-2325. Acta Derm Venereol. 2016. PMID: 26694951 Free article.
Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine.
Abraham-Nordling M, Wallin G, Träisk F, Berg G, Calissendorff J, Hallengren B, Hedner P, Lantz M, Nyström E, Asman P, Lundell G, Törring O; Thyroid Study Group of TT 96. Abraham-Nordling M, et al. Eur J Endocrinol. 2010 Oct;163(4):651-7. doi: 10.1530/EJE-10-0475. Epub 2010 Jul 21. Eur J Endocrinol. 2010. PMID: 20660002 Clinical Trial.
Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial.
Eastell R, Lang T, Boonen S, Cummings S, Delmas PD, Cauley JA, Horowitz Z, Kerzberg E, Bianchi G, Kendler D, Leung P, Man Z, Mesenbrink P, Eriksen EF, Black DM; HORIZON Pivotal Fracture Trial. Eastell R, et al. Osteoporos Int. 2010 Jul;21(7):1277-85. doi: 10.1007/s00198-009-1077-9. Epub 2009 Oct 3. Osteoporos Int. 2010. PMID: 19802508 Free PMC article. Clinical Trial.
Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131.
Träisk F, Tallstedt L, Abraham-Nordling M, Andersson T, Berg G, Calissendorff J, Hallengren B, Hedner P, Lantz M, Nyström E, Ponjavic V, Taube A, Törring O, Wallin G, Asman P, Lundell G; Thyroid Study Group of TT 96. Träisk F, et al. J Clin Endocrinol Metab. 2009 Oct;94(10):3700-7. doi: 10.1210/jc.2009-0747. Epub 2009 Sep 1. J Clin Endocrinol Metab. 2009. PMID: 19723755 Clinical Trial.